KAREN GROSS: Open Payments
NPI 1518170596 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 81 payments from 19 companies in 2025. Trend: 2023 $2,484 · 2024 $1,934 · 2025 $1,443
Food & beverage: $1,395Education: $48
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $234 |
| ABBVIE INC. | 11 | $168 |
| Otsuka America Pharmaceutical, Inc. | 10 | $167 |
| PFIZER INC. | 11 | $147 |
| Lundbeck LLC | 8 | $143 |
| Abbott Laboratories | 6 | $102 |
| Axsome Therapeutics, Inc. | 6 | $100 |
| Novo Nordisk Inc | 5 | $89 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| Exact Sciences Corporation | 2 | $35 |
Products named: REXULTI, FARXIGA, FREESTYLE LIBRE 3, Auvelity, NURTEC ODT, QULIPTA, VRAYLAR, TZIELD.
Industry payments across MO — which companies pay providers there.
